Developer of gene therapies for the treatment of multiple disease conditions. The company uses CRISPR-Cas9 and other gene-editing methods to develop bacterial vector gene therapy for targeted therapeutics. The company has developed drug candidates for cancer, Inflammatory bowel disease, and Phenylketonuria.